Pfizer INDovation Programme to support breakthrough healthcare innovations in India
Startups in India have been leading innovators in the healthcare sector. In addition to increasing provider and supplier capacity, they enable patients to understand and track their own treatment pathways. Nevertheless, for these startups to become successful businesses and scale globally, they must find an enabling ecosystem that can help them accelerate their lab-to-market journey. A strong go-to-market strategy, support for clinical testing and validation, and obtaining regulatory approvals greatly increase the likelihood of success for healthtech startups.
To support this journey, Atal Innovation Mission, NITI Aayog, Agnii, Foundation for Innovation and Technology Transfer (FITT), IIT-Delhi, Pfizer and Social Alpha have come together to launch the Pfizer INDovation Program to support breakthrough healthcare innovations by start-ups in India.
RELEVANT SUSTAINABLE GOALS
What is Pfizer INDovation?
The Pfizer INDovation Program brings together various stakeholders such as the Atal Innovation Mission, NITI Aayog, Foundation for Innovation and Technology Transfer (FITT), IIT-Delhi, Agnii, amongst others on the same platform to equip India’s healthcare systems for a post COVID-19 world. The two-year initiative will guide high-quality startups, having at least a tested prototype, and accelerate their journey through product engineering and development services, clinical validation support, regulatory advisory, and market access opportunities through grant support and catalytic cross-industrial collaborations. The program is designed to have two tracks – one focused on Digital Health to enable and improve access, affordability, and workforce efficiency, while increasing patient engagement and adherence and another on Oncology to cater to the increasing number of patients being diagnosed with cancer
Digital Health is projected to profoundly affect many aspects of healthcare delivery, including promotions, preventions, primary care, and specialised care. This track of the program will focus on nurturing startups building solutions to enable and improve access to quality and care delivery, along with workforce efficiency. This includes startups focused on digital OPDs, smart supply chains, digital clinical trials, AL/ML solutions, amongst others.
Who Can Apply ?
Innovators and entrepreneurs building science and technology solutions, that have:
- A prototype in early or late-stage validation or above (TRL 4-5 or above)
- The potential to create and scale impact
- In markets across different geographies, and
- Has a sustainable business model
The program will focus on high problem statements in areas of digital health and oncology that have been selected after consultation with the program partners and advisors. The eligible enterprises working in any of the following areas are encouraged to apply:
Timelines
For any assistance, please reach out to us at pfizerindovation@socialalpha.org.
ABOUT SOCIAL ALPHA:
Social Alpha is an initiative to strengthen the science and technology start-up ecosystem in India with a focus on “lab to market” enablement. Since its inception in 2016, Social Alpha has nurtured more than 50 mission driven start-up. Social Alpha architecture integrates the innovation, incubation and investment ecosystems and allows for an effective mechanism for allocating resources to mission driven entrepreneurs throughout their lab to market progression
The article was initially published on 28th April 2022.
You may also be interested in :
No Blue Liquid Here! Normalising Periods Begins With Showing The Actual Blood
Never miss a story. Join us on social.